Benefits of prophylactic carotid revascularization in patients with asymptomatic carotid artery stenosis undergoing coronary artery bypass surgery: A narrative review

Abstract

Patients undergoing coronary artery bypass grafting (CABG) are at increased risk of perioperative stroke. Carotid atherosclerosis has been identified as an independent risk factor for stroke during and in the early postoperative period of cardiac surgery. However, the pathogenesis of peri-CABG stroke is multifactorial and frequently involves other noncarotid causes, such as cardiac emboli and aortic atheroma. Therefore, routine population-wide screening of carotid stenosis is not recommended, but target screening of patients at high risk of carotid-related perioperative stroke can have benefits. Carotid duplex sonography is recommended as an initial screening tool. Elimination of carotid stenosis before cardiac surgery is indicated in patients in whom carotid atherosclerosis is suspected to be the primary contributor to perioperative stroke. In patients with advanced carotid atherosclerosis, an individualized revascularization approach, including simultaneous or staged procedures, is advocated. The prevailing consensus is that synchronous surgery is safer than staged procedures. Carotid artery stenting represents a less invasive alternative, but its role in high-risk patients requires further investigation. In conclusion, the risk of perioperative stroke in patients undergoing CABG involves different factors, and carotid artery stenosis is involved in its pathogenesis only in some patients. Therefore, individualized approaches and careful consideration of patient risk factors are essential in determining the need for carotid screening and revascularization before CABG.

Keywords

carotid atherosclerosis coronary surgery perioperative stroke revascularization risk assessment

Introduction

Atherosclerosis is a systemic condition that can concurrently affect multiple arterial beds. Between 2% and 14% of patients have coexistent coronary (CAD) and carotid artery disease. Of those undergoing coronary artery bypass grafting (CABG), 8% have significant carotid artery stenosis.¹ Conversely, clinically evident CAD is present in nearly one-third of patients with advanced carotid stenosis in whom carotid endarterectomy (CEA) is indicated, and in patients undergoing CEA, the prevalence of CAD is much higher and was found in 40–50%.²

Stroke remains a major cause of morbidity and mortality after CABG. The period of stroke related to CABG is divided into three categories: intraoperative (detected immediately after extubating the patient), early postoperative (7 days after the operation), and late (beyond 7 days). Intraoperative and early postoperative stroke are also categorized as perioperative stroke.³ The general risk of perioperative stroke in patients with CABG is between 1.3% and 2.0%, and its etiology differs.^4,5 The main causes of stroke during the operative procedures are thromboembolism and hypoperfusion. Most strokes that occur during the first 7 postoperative days are related to arrhythmias and low cardiac output syndrome, but the late stroke is usually thromboembolic and is caused by the progression of cerebrovascular atherosclerosis and atrial fibrillation.⁶ Extracranial carotid disease has been shown to be involved in the etiology of perioperative CABG stroke. However, the data indicate that only advanced carotid atherosclerosis – severe unilateral stenosis (> 70%) or occlusion, bilateral stenosis, and unfavorable morphologic characteristics of the carotid lesion (e.g., ulceration) – independently predict an increased risk of stroke during cardiac CABG.⁷ Most intraoperative strokes (70–80%) are caused by thromboembolism because of aortic manipulation or atrial fibrillation, and 20–30% follow hypoperfusion secondary to hypotension.^6,7 Older age, female sex, diabetes mellitus, hypertension, left main CAD, peripheral vascular disease, advanced atherosclerosis of the aortic arch, and carotid stenosis were identified as important risk factors for perioperative stroke.^8,9 Perioperative stroke is related to high mortality. A meta-analysis of 34 articles, which included 174,969 patients with cardiac operations, showed that the pooled event rate for early (intraoperative) stroke was 0.98% (95% CI 0.79 to 1.23) and delayed (postoperative) stroke occurred in 0.93% (95% CI 0.73 to 1.11; p = 0.68). Intraoperative stroke had a 30-day mortality of 29%, those with postoperative stroke 18%, and in patients with no stroke, perioperative mortality was only 2.4%.³ The incidence of perioperative stroke varies among different types of surgical procedures, and in CABG it accounts for an average of 2%.¹⁰

This review summarizes the current evidence on the pathogenesis of stroke after CABG and suggests strategies for patients in need of investigation of carotid arteries before CABG to reduce the risk of stroke related to carotid lesions.

Methods

This article is a narrative review. A comprehensive search was performed to identify studies examining the incidence and risk of carotid atherosclerosis and the need for carotid revascularization before CABG. The following databases were searched: Ovid Medline, Ovid Embase, and Cochrane Library. The most relevant papers, according to methodological and clinical considerations, were selected.

Causes of stroke related to carotid artery disease during cardiac surgery

Carotid atherosclerosis is involved in the pathogenesis of CABG-associated perioperative stroke only in some patients. Less than 50% of patients suffering from stroke will not have significant carotid disease, and a quarter of strokes result from embolic events related to carotid artery stenosis. Only severe carotid artery stenosis (80–99%) represents the risk of perioperative stroke¹¹ (Table 1). In a prospective multicenter observational study involving 2813 patients undergoing CABG, asymptomatic carotid stenosis greater than 50% was identified in 26% of the patients, whereas carotid occlusion was found in 1.1% of cases.¹² In patients undergoing CABG without significant carotid lesions, the stroke rate is less than 2%.^7,13 The stroke rate increases with the progression of atherosclerosis: in asymptomatic carotid lesions it is about 3% if a patient has unilateral 50–99% carotid stenosis, 5% in those with bilateral 50–99% stenosis, and 7–11% in those with carotid occlusion.¹⁰ This review additionally demonstrated that half of the stroke patients during the perioperative period lacked significant carotid disease, and up to 60% did not exhibit territorial infarctions on autopsy/computed tomography that aligned with carotid disease patterns. However, patients undergoing CABG with prior transient ischemic attack (TIA) or stroke had the highest rate of postoperative stroke.¹⁰ In the study by Chen et al., the incidence of post-CABG stroke was 1.7%: 8% in patients with severe (> 70%) carotid stenosis and 0.0% with nonsevere carotid stenosis.⁷ The systemic review of 36 observational studies showed that prior stroke was the most important predictor of perioperative stroke, whereas carotid stenosis was not a statistically significant predictor of stroke.³ Besides carotid stenosis there is also an interrelationship between other cerebrovascular diseases and perioperative CABG stroke.¹⁴ A retrospective cohort study, which included 20,241 patients undergoing CABG, showed that the risk of post-CABG stroke increased with the degree of carotid stenosis. An almost threefold increased risk of postoperative neurologic events occurred in patients with 80–90% carotid stenosis in comparison to those with 50–79%.¹⁵ These findings indicate that the risk of perioperative CABG stroke increases with the severity of carotid stenosis, but only in advanced forms of carotid atherosclerosis. Different studies otherwise showed that carotid endarterectomy decreases the 5-year risk of ipsilateral stroke in patients with asymptomatic isolated carotid disease.⁴ However, the long-term risk reduction of stroke by operative procedure should not be used as a justification for performing carotid revascularization in patients undergoing CABG.

Table 1.

Mechanisms of stroke in patients undergoing CABG.

Study	Patients	Findings
Carotid stenosis
Naylor, et al.¹⁰ (review)	167 prospective and retrospective studies 190,449 pts undergoing CABG	Stroke incidence: • unilateral CS (50–99%): 3% • bilateral CS (50–99%): 5% • carotid occlusion: 7–11%
Chen, et al.⁷ (cohort study)	1799 pts undergoing CABG	Stroke incidence: • average: 1.7% • severe CS (> 70%): 8.0% • nonsevere CS: 0.0%
Gaudino, et al.³ (review)	36 observational studies – pts undergoing CABG	Stroke incidence 1.3%: • prior stroke was most important predictor of post-CABG stroke • CS was not significant predictor of stroke
Ruka, et al.¹⁵ (cohort study)	20,241 pts undergoing CABG	The risk of post-CABG stroke increases with severity of CS: • threefold increased risk in pts with 80–99% CS in comparison to 50–79% CS
Aortic arch atherosclerosis and manipulation
Gelsomino, et al.²⁶ (cohort study)	16,255 pts undergoing CABG	Aortic cross-clamping was the primary cause of post-CABG embolic stroke
Gaudino, et al.³(review)	Review of observational studies undergoing CABG	Atherosclerosis of ascending aorta was documented in > 50% of pts undergoing CABG and was related to stroke
van der Linden, et al.³⁰(cohort study)	921 consecutive pts undergoing CABG	Atherosclerosis of ascending aorta in 26.2% of pts Stroke rate: • pts without aortic AS: 1.8% • pts with aortic AS: 8.79%
Atrial fibrillation
Megens, et al.³² (review)	108,711 pts undergoing CABG	• New-onset atrial fibrillation after CABG was related to increased risk of stroke

AS, atherosclerosis; CABG, coronary artery bypass grafting; CS, carotid stenosis; pts, patients.

There are different mechanisms by which carotid artery stenosis could lead to perioperative stroke. It was shown that carotid intraplaque hemorrhage can destabilize plaque and cause thromboembolism. Intraplaque hemorrhage is associated with an increased risk of ipsilateral stroke.^16–18 Administering anticoagulants during CABG may contribute to an increased risk of carotid intraplaque hemorrhage during operation.¹⁹ At the same time, additional mechanical factors, such as turbulent blood flow and hypertension, can also trigger this event.²⁰ Further, plaque morphology influences the cardiovascular thromboembolic event rate. It includes lipid reach plaque, extensive plaque, thin fibrous cap, heavily calcified plaque, and stenosis at the bifurcation involving both internal and external carotid arteries.²¹ Impaired cerebral autoregulation distal to carotid stenosis is another risk factor of perioperative stroke, which causes cerebral ischemia and is associated with an increased risk of stroke.²²

Noncarotid causes of stroke during cardiac surgery

The cause of peri-CABG stroke is multifactorial and is frequently caused by noncarotid causes. There are no studies that have systematically assessed stroke risk in asymptomatic carotid patients and identified those subjects with asymptomatic carotid stenosis for whom CABG without carotid revascularization poses a greater risk of stroke compared to prior carotid surgery.

Carotid atherosclerosis as a cause of stroke during CABG is probably overestimated. Particularly in patients with asymptomatic carotid stenosis, CABG stroke is more likely to be caused by noncarotid atherosclerosis, including cardiac emboli and atherosclerotic lesions in the ascending aorta.²³

Manipulation of the aorta represents one of the main causes of perioperative CABG stroke²⁴ (Table 1). In this study, two-thirds of strokes occurred after surgery. This indicates that hemodynamic deterioration during surgical procedures has a less important role in the pathogenesis of perioperative stroke. The studies also showed that 70% of perioperative strokes are bilateral or multiple. This indicates that the sources of emboli are not carotid arteries but proximal territories, including the ascending aorta.^3,25

Macroembolization with atherothrombotic material from the atherosclerotic deteriorated aorta is typically related to CABG-provoked postoperative stroke.²⁶ Further, intracardial thrombus and intermittent clamping of the aorta during surgery are predictors of major perioperative stroke.²⁷ The dislodgement of emboli from the ascending aorta, potentially triggered by its manipulation during surgery, can provoke embolic stroke.²⁸ The risk of CABG stroke correlates closely with the presence or absence of extended (> 5 mm into the aorta lumen) ulcerated plaques or the presence of multiple aortic atheromas. Patients with severe aortic disease, represented by porcelain aorta, which is characterized by circumferential calcification throughout the whole perimeter of the aorta, have a 5–19% risk of perioperative stroke compared with 0–2% in patients who do not have a significant aortic atherosclerotic disease.²⁹ In the study by van der Linden et al., which included 921 consecutive patients undergoing cardiac surgery, 26.2% of patients had atherosclerosis of the ascending aorta.³⁰ The incidence of stroke was 1.8% in patients without atherosclerotic disease of the ascending aorta and 8.7% in patients with aortic disease.³⁰ It indicates that evaluation of atherosclerotic deterioration of the ascending aorta may improve risk stratification of stroke prior to CABG.³¹ A significant cause of embolic stroke is also atrial fibrillation and mobilization of blood clots from the heart during manipulation by the surgeon.^32,33 Also, atherosclerotic lesions of cerebral arteries can cause embolic stroke in patients undergoing CABG. All these factors are important in the pathogenesis of perioperative stroke, as approximately 45–50% of coronary patients also exhibit severe aortic and intracranial atherosclerotic disease.³⁴ Therefore, perioperative stroke is not merely the consequence of carotid atherosclerosis, but the other noncarotid risk factors must be borne in mind.

In patients undergoing CABG, the risk of stroke is also related to the operative procedure. Off-pump surgery reduces the amount of aortic manipulation by avoiding cannulation and cross-clamping. A meta-analysis found that on-pump CABG was associated with an increased incidence of stroke in comparison to off-pump CABG.³⁵ Therefore, the preoperative treatment of asymptomatic carotid stenosis cannot completely prevent perioperative strokes. One of the systemic reviews showed that prophylactic carotid revascularization could prevent only 40–50% of strokes in patients undergoing CABG.¹⁰ Particularly in patients with significant cardiac and/or aortic atherosclerotic disease, carotid revascularization would prevent fewer perioperative strokes.

Carotid screening before CABG

Carotid duplex sonography (DUS) is the most widely utilized screening method to assess carotid arteries, particularly the degree of stenosis. This noninvasive technique employs B-mode and Doppler imaging to evaluate blood flow within the carotid arteries. Carotid DUS offers extensive availability and excellent sensitivity (94%).³⁶ Alternative noninvasive diagnostic test options include computer tomography angiography (CTA) and magnetic resonance angiography (MRA). Despite their advantages, MRA and CTA present limitations. MRA may overestimate the degree of stenosis, whereas the value of CTA’s evaluation of calcified lesions is limited. Additionally, both techniques struggle to distinguish between subtotal and complete arterial occlusion.³⁷ Catheter-based angiography offers a more detailed anatomical view of arteries than traditional angiography. Because of the invasiveness, it is usually used before therapeutic interventions such as CAS.³⁸

Besides the degree of stenosis, plaque morphology influences plaque vulnerability (rupture) and is related to thromboembolic events. Identification of vulnerable plaque, irrespective of the degree of stenosis, can help to identify patients who are at the highest risk of thromboembolic carotid-related embolic events during CABG.²¹ Therefore, the degree of stenosis alone is not sufficient to decide which patients are at the highest risk of perioperative stroke. Noninvasive imaging and invasive techniques are used to determine plaque morphology.³⁹ Ultrasound B-mode ultrasonography and contrast-enhanced ultrasonography are the two most widely used techniques for assessing carotid plaque morphology. Further, high-resolution magnetic resonance imaging is currently considered the most competitive imaging method for the examination of the carotid artery wall morphology.⁴⁰ Positron emission tomography assesses intraplaque inflammation and angiogenesis. Intravascular ultrasound enables the presentation of two-dimensional images in real time, displaying different components of the vessel wall.^41,42

Carotid stenosis is common in patients with CAD, but only a few carotid lesions are related to perioperative stroke. Therefore, the effectiveness of nonselective carotid screening in patients undergoing CABG is unknown. Further, selective or nonselective carotid DUS screening identifies only a low proportion of patients who will develop perioperative stroke.³⁶ However, despite this finding, most (approximately 90%) of carotid revascularizations are performed on neurologically asymptomatic patients.⁴³ Also, observational data showed that the risk of stroke in neurologically asymptomatic patients with unilateral 70–99% stenosis undergoing CABG is exceedingly low.² Furthermore, with the combined operation of carotid and coronary arteries, an increased risk of morbidity and mortality due to the potential risk of stroke and acute myocardial infarction (AMI) is expected.⁴⁴ Therefore, it indicates again that carotid revascularization before or in combination with CABG might not significantly decrease the risk of neurologic complications, particularly in asymptomatic patients. Consequently, prophylactic investigation and revascularization of carotid arteries may be of no significant benefit in preventing perioperative stroke.⁴⁵ The significant advantage of carotid revascularization in patients undergoing CABG is expected only in those patients with a history of neurologic events (TIA or stroke) and severe carotid atherosclerotic lesions.⁴⁶ Also, recent guidelines do not recommend population-wide screening of asymptomatic carotid stenosis by duplex ultrasound.⁴⁷ European Society of Vascular Surgery (ESVS) guidelines concluded that in patients undergoing open heart surgery, routine carotid surgery is not recommended (Class III, Level of evidence: C).⁴⁸ The ACC Foundation/AHA Task Force on Practice Guidelines recommend that performing carotid DUS is justifiable in specific patients identified with high-risk factors, including individuals aged over 65 years, those with a carotid bruit, left main coronary artery stenosis, peripheral artery disease, hypertension, a history of smoking, diabetes mellitus, and a past medical history of cerebrovascular disease (stroke or TIA) or cervical carotid disease (Class IIa, Level of evidence: C)⁴⁹ (Figure 1). Also, the Society of Vascular and Interventional Neurology suggested screening a specific group of patients with suspected carotid lesions undergoing CABG (grade B recommendation).⁵⁰

Figure 1.

Screening and management of carotid stenosis (CS) in patients undergoing coronary artery bypass grafting (CABG).

Besides detecting carotid atherosclerosis using imaging techniques in subjects undergoing CABG, clinical variables alone can help identify patients with significant carotid artery disease who may need additional investigation.⁴

Risk of carotid revascularization procedures in patients undergoing CABG surgery

Carotid revascularization is accepted and well supported by evidence from patients undergoing CABG who have symptomatic carotid disease, bilateral 70–99% carotid stenosis, or unilateral 70–99% stenosis with contralateral carotid occlusion^48,51 (Figure 2). Nevertheless, these procedures are mainly carried out preventively in patients with asymptomatic unilateral carotid stenosis. The effectiveness and significance of such preventive measures remain uncertain.^52,53 Various findings did not answer the question of the utility of carotid revascularization in asymptomatic patients undergoing CABG due to the absence of a direct relationship between carotid artery atherosclerosis and perioperative ipsilateral stroke.⁵⁴

Figure 2.

Management of patients with carotid stenosis (CS) undergoing coronary artery bypass grafting (CABG).

The optimal approach for carotid and coronary revascularization remains controversial. Different treatment strategies exist, which include combined or synchronous surgical procedures where CABG and CEA are performed simultaneously; in staged surgical procedures, where CABG is performed with subsequent CEA or CEA with subsequent CABG; and hybrid techniques, which consist of CABG with carotid artery stenting (CAS) or percutaneous coronary intervention (PCI), and percutaneous procedures, which combine PCI with CAS.² There is currently no consensus on the temporal sequence of revascularization of carotid and coronary arteries in patients undergoing CABG, with evidence supporting both simultaneous and staged procedures.⁵⁵

A systemic review and meta-analysis showed a significantly higher risk of stroke and death, but a lower risk of AMI with the combined compared to the staged procedures.⁵⁶ In detail, the synchronous approach is associated with elevated stroke and mortality rates, ranging from 7.4% to 9.4%,⁵⁷ which is significantly higher than the risk of each operation alone. Another review of 1160 procedures found an even greater risk of stroke and/or death in patients with synchronous CEA and CABG. Notably, 18.6% of patients in this group experienced these adverse events.⁵⁸ A systematic review analyzing 7863 patients with combined CEA and CABG revealed a nonnegligible cardiovascular risk associated with the combined procedure.⁵⁹ In this review, a significant reduction in the risk of death/stroke was observed in studies published between 1993 and 2002 compared with those from 1972 to 1992 (7.2% (95% CI 6.5 to 9.1) versus 10.7% (95% CI 8.9 to 12.5), p = 0.03). Notably, similar information was unavailable for a comparable cohort of patients with CABG in whom prophylactic CEA was not performed. Therefore, recently, the need for revascularization of carotid arteries has probably been reduced entirely.

Consistent with the elevated risk observed in synchronous procedures, patients who underwent CEA prior to CABG also faced increased complication rates. The CEA guidelines prepared by the Stroke Council and American Heart Association registered a 16.44% incidence of stroke, AMI, and death in patients with combined CEA and CABG.⁶⁰ This risk remained substantial even with staged procedures, with 26.15% for CEA followed by CABG and 16.35% for CABG followed by CEA. According to the ESVS, for patients with concomitant severe coronary and carotid artery disease, an individualized surgical approach is recommended.⁴⁸ Owing to the substantial operative complication rate associated with carotid surgery, either as an alone procedure or in conjunction with CABG, the long-term benefits of secondary stroke prevention are expected to be limited to high-risk patient populations.

Strategies for enhanced perioperative neurological safety in CABG procedures

To mitigate the risk of perioperative neurological events in patients undergoing CABG, several strategies can be implemented, including meticulous blood pressure monitoring throughout the procedure and postoperatively. Maintaining normotension is crucial, as both hypertension and hypotension pose significant risks. Hypertension can provoke cerebral bleeding, whereas hypotension can lead to cerebral ischemia, both of which can have detrimental neurological consequences.⁶¹ Intraoperative assessment of the aorta is recommended before clamping, and it should be followed by procedures to decrease the shedding of emboli from the aorta during surgery.²⁶

No statistically significant difference was observed in the risk of death or stroke when comparing pre- versus on-cardiopulmonary bypass timing of CEA.⁵⁹ However, several smaller studies suggested potentially improved outcomes when combining CEA with off-pump cardiopulmonary bypass.^62,63

Carotid artery stenting (CAS) in patients undergoing CABG with high surgical risk

CAS has emerged as a promising alternative to CEA for the treatment of carotid artery disease. In the past, several small studies have indicated a significantly lower complication rate among patients undergoing CAS followed by CABG compared to those undergoing combined CEA and CABG.⁶⁴ Also, a meta-analysis of outcomes 30 days after the procedure showed that CAS before CABG or CAS plus CABG is an attractive and less invasive procedure than CEA plus CABG.⁶⁵ A systemic review, including 23 studies encompassing 873 and 459 patients in the staged and synchronous groups, evaluated the comparative outcomes of synchronous versus staged CAS and CABG in patients with concomitant carotid and CAD.⁶⁶ The overall death/stroke/AMI rate was 8.5% (95% CI 7.6 to 9.4) in the staged group and 4.8% (95% CI 3.8 to 5.8) in the synchronous group, suggesting a potential advantage of the simultaneous approach. However, due to the limitations of available data, statistical comparisons between the two groups were not feasible.

Another meta-analysis, which included 80% of patients with asymptomatic carotid stenosis, has shown similar mortality of staged CAS + CABG and synchronous CAS + CABG. However, there was a higher risk of stroke and AMI with staged CAS + CABG.⁶⁷ Feldman et al. examined 22,501 patients who had three different revascularization methods, and they found significantly lower rates (1.9%) of in-hospital death in CAS + CABG than in combined CEA + CABG (4.4%) and 3.8% in staged CEA + CABG.⁶⁸ The studies also showed that staged or simultaneous CAS and percutaneous coronary procedures have outcomes similar to hybrid surgical interventions.⁶⁹ Although the number of reported studies and included patients was small, the data support the validity of hybrid (CABG + CAS) revascularization, particularly in high-risk surgical patients.

Recently, a new, less invasive trans carotid artery revascularization (TCAR) was developed, which provides minimal invasive revascularization with stenting of the stenotic carotid arteries using direct carotid access while simultaneously reversing the flow of blood in the carotid artery aimed at minimizing the risk of stroke during the revascularization process.⁷⁰ The TCAR procedure can be performed under local anesthesia, and it minimizes aortic arch manipulation and consequently reduces antegrade embolic stroke rate. The preliminary outcomes of TCAR in high-risk patients seem to be more favorable than those of transfemoral CAS.⁷¹ A retrospective study by Vyas et al. examined 14 patients with either symptomatic carotid artery stenosis greater than 50% or asymptomatic carotid artery stenosis greater than 70% alongside either contralateral internal carotid artery occlusion or widespread cerebral occlusive disease observed on radiographic imaging. These patients underwent staged TCAR before CABG surgery. Over a 12-month follow-up period, there were no reported cases of perioperative stroke, myocardial infarction, or death.⁷²

Performing TCAR with flow reversal concurrently with CABG has been recently suggested as an alternative approach for carotid artery revascularization in a patient with severe concomitant carotid and CAD.⁷³ In this case, TCAR is performed through a median sternotomy, which also mitigates stroke risk by avoiding aortic arch manipulation. However, the challenge with this approach is that patients cannot be on dual antiplatelet therapy before surgery, and the loading dose of clopidogrel can only be administered after the CABG procedure. Clopidogrel takes approximately 2 hours to reach its full effect, leaving the stent potentially unprotected during this period.

Conclusions

Patients with advanced carotid atherosclerosis who undergo CABG are at an elevated risk of stroke provoked by surgery. The risk is highest in patients with a history of stroke or TIA. However, beyond carotid atherosclerosis, other risk factors, particularly advanced cardiac and aortic atherosclerotic disease, also contribute to perioperative stroke. Consequently, screening for carotid artery stenosis prior to CABG is only recommended for patients with expected advanced atherosclerotic carotid lesions and concomitant atherosclerosis in other vascular beds. In patients with asymptomatic carotid stenosis, elimination of risk factors and best medical treatment represent basic therapeutic options. Elimination of carotid stenosis before coronary surgery is indicated in patients at high risk of perioperative stroke, where carotid atherosclerosis is suspected to be the primary contributor.

An individualized surgical approach is advocated as the most adequate management strategy in patients with CAD and advanced carotid artery disease. When considering surgical revascularization, choosing between synchronous or staged carotid revascularization and CABG is exacting. The prevailing consensus is that synchronous surgery is safer than staged procedures. For high-risk surgical patients, CAS represents a less invasive alternative prior to CABG.

Footnotes

Declaration of conflicting interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

*

These authors contributed equally to this work.

ORCID iDs

Pavel Poredos

Peter Poredos

References

Mufti

Alshaltoni

AlGahtani

, et al. Role of carotid artery ultrasound duplex prior to cardiac surgery in adults in predicting neurocognitive complications. Cureus 2020; 12: e11211.

Manthey

Spears

Goldberg

Coexisting coronary and carotid artery disease – Which technique and in which order? Case report and review of literature. Clin Med Insights Cardiol 2020; 14: 1179546820951797.

Gaudino

Rahouma

Di Mauro

, et al. Early versus delayed stroke after cardiac surgery: A systematic review and meta-analysis. J Am Heart Assoc 2019; 8: e012447.

Masabni

Raza

Blackstone

, et al. Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? J Thorac Cardiovasc Surg 2015; 149: 1253–1260.

Ozatik

Göl

Fansa

, et al. Risk factors for stroke following coronary artery bypass operations. J Card Surg 2005; 20: 52–57.

Gaudino

Angiolillo

Di Franco

, et al. Stroke after coronary artery bypass grafting and percutaneous coronary intervention: Incidence, pathogenesis, and outcomes. J Am Heart Assoc 2019; 8: e013032.

Chen

Zhang

, et al. The role of carotid artery stenosis in predicting stroke after coronary artery bypass grafting in a Chinese cohort study. Sci Rep 2023; 13: 21536.

Palmerini

Savini

Di Eusanio

Risks of stroke after coronary artery bypass graft – Recent insights and perspectives. Interv Cardiol 2014; 9: 77–83.

Asta

Falco

Benedetto

, et al. Stroke after cardiac surgery: A risk factor analysis of 580,117 patients from UK National Adult Cardiac Surgical Audit cohort. J Pers Med 2024; 14: 169.

10.

Naylor

Mehta

Rothwell

Bell

PR.

Carotid artery disease and stroke during coronary artery bypass: A critical review of the literature. Eur J Vasc Endovasc Surg 2002; 23: 283–294.

11.

Högberg

Björck

Mani

, et al. Five year outcomes in men screened for carotid artery stenosis at 65 years of age: A population based cohort study. Eur J Vasc Endovasc Surg 2019; 57: 759–766.

12.

Santarpino

Nicolini

De Feo

, et al. Prognostic impact of asymptomatic carotid artery stenosis in patients undergoing coronary artery bypass grafting. Eur J Vasc Endovasc Surg 2018; 56: 741–748.

13.

Jannati

Risk factors for stroke post coronary artery bypass graft surgery: A review of literature. Medicina Clínica Práctica 2024; 7: 100405.

14.

Sultan

Bianco

Kilic

, et al. Predictors and outcomes of ischemic stroke after cardiac surgery. Ann Thorac Surg 2020; 110: 448–456.

15.

Ruka

Lesur

Gingras

, et al. Relationship between the degree of carotid stenosis and the risk of stroke in patients undergoing cardiac surgery. Can J Cardiol 2022; 38: 347–354.

16.

Nardi

Benson

Bois

, et al. Carotid plaques from symptomatic patients with mild stenosis is associated with intraplaque hemorrhage. Hypertension 2022; 79: 271–282.

17.

Larson

Brinjikji

Savastano

, et al. Carotid intraplaque hemorrhage and stenosis: At what stage of plaque progression does intraplaque hemorrhage occur, and when is it most likely to be associated with symptoms? AJNR Am J Neuroradiol 2021; 42: 1285–1290.

18.

Lusby

Ferrell

Ehrenfeld

, et al. Carotid plaque hemorrhage. Its role in production of cerebral ischemia. Arch Surg 1982; 117: 1479–1488.

19.

Mujaj

Bos

Muka

, et al. Antithrombotic treatment is associated with intraplaque haemorrhage in the atherosclerotic carotid artery: A cross-sectional analysis of The Rotterdam Study. Eur Heart J 2018; 39: 3369–3376.

20.

Rigatelli

Zuin

Ngo

, et al. Intracoronary cavitation as a cause of plaque rupture and thrombosis propagation in patients with acute myocardial infarction: A computational study. J Transl Int Med 2019; 7: 69–75.

21.

Bentzon

Otsuka

Virmani

Falk

Mechanisms of plaque formation and rupture. Circ Res 2014; 114: 1852–1866.

22.

Schoof

Lubahn

Baeumer

, et al. Impaired cerebral autoregulation distal to carotid stenosis/occlusion is associated with increased risk of stroke at cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 2007; 134: 690–696.

23.

D’Ancona

Saez de Ibarra

Baillot

, et al. Determinants of stroke after coronary artery bypass grafting. Eur J Cardiothorac Surg 2003; 24: 552–556.

24.

Ferrante

Pisano

Van Rothem

, et al. Cerebrovascular events after cardiovascular surgery: Diagnosis, management and prevention strategies. Kardiochir Torakochirurgia Pol 2023; 20: 118–122.

25.

Likosky

Caplan

Weintraub

, et al. Intraoperative and postoperative variables associated with strokes following cardiac surgery. Heart Surg Forum 2004; 7: E271–276.

26.

Gelsomino

Tetta

Matteucci

, et al. Surgical risk factors for ischemic stroke following coronary artery bypass grafting. A multi-factor multimodel analysis. Front Cardiovasc Med 2021; 8: 622480.

27.

Wolman

Nussmeier

Aggarwal

, et al. Cerebral injury after cardiac surgery: Identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators. Stroke 1999; 30: 514–522.

28.

Stamou

Hill

Dangas

, et al. Stroke after coronary artery bypass: Incidence, predictors, and clinical outcome. Stroke 2001; 32: 1508–1513.

29.

Roach

Kanchuger

Mangano

, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996; 335: 1857–1863.

30.

van der Linden

Hadjinikolaou

Bergman

Lindblom

. Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol 2001; 38: 131–135.

31.

Asenbaum

Nolz

Puchner

, et al. Coronary artery bypass grafting and perioperative stroke: Imaging of atherosclerotic plaques in the ascending aorta with ungated high-pitch CT-angiography. Sci Rep 2020; 10: 13909.

32.

Megens

Churilov

Thijs

New-onset atrial fibrillation after coronary artery bypass graft and long-term risk of stroke: A meta-analysis. J Am Heart Assoc 2017; 6: e007558.

33.

Roffi

Ribichini

Castriota

Cremonesi

Management of combined severe carotid and coronary artery disease. Curr Cardiol Rep 2012; 14: 125–134.

34.

Hoshino

Sissani

Labreuche

, et al. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. JAMA Neurol 2018; 75: 203–211.

35.

Wang

Gao

, et al. Comparison of the incidence of postoperative neurologic complications after on-pump versus off-pump coronary artery bypass grafting in high-risk patients: A meta-analysis of 11 studies. Int J Cardiol 2015; 185: 195–197.

36.

Jonas

Feltner

Amick

, et al. Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 161: 336–346.

37.

Brott

Halperin

Abbara

, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol 2011; 57: e16–94.

38.

McPhee

Schanzer

Messina

Eslami

MH.

Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States, 2005. J Vasc Surg 2008; 48: 1442–1450, 1450.e1.

39.

Weng

Lai

Cai

, et al. Detecting vulnerable carotid plaque and its component characteristics: Progress in related imaging techniques. Front Neurol 2022; 13: 982147.

40.

Kassem

Florea

Mottaghy

, et al. Magnetic resonance imaging of carotid plaques: Current status and clinical perspectives. Ann Transl Med 2020; 8: 1266.

41.

Mushenkova

Summerhill

Zhang

, et al. Current advances in the diagnostic imaging of atherosclerosis: Insights into the pathophysiology of vulnerable plaque. Int J Mol Sci 2020; 21: 2992.

42.

Murgia

Balestrieri

Francone

, et al. Plaque imaging volume analysis: Technique and application. Cardiovasc Diagn Ther 2020; 10: 1032–1047.

43.

Bagley

Priest

Carotid revascularization: Current practice and future directions. Semin Intervent Radiol 2020; 37: 132–139.

44.

Naylor

AR.

Managing patients with symptomatic coronary and carotid artery disease. Perspect Vasc Surg Endovasc Ther 2010; 22: 70–76.

45.

Paraskevas

Nicolaides

Spence

, et al. Clarifying the rationale supporting selective screening for asymptomatic carotid artery stenosis. Int J Cardiol 2023; 376: 174–175.

46.

Mortaz Hejri

Mostafazadeh Davani

Sahraian

. Carotid endarterectomy for carotid stenosis in patients selected for coronary artery bypass graft surgery. Cochrane Database Syst Rev 2009; 2009: CD006074.

47.

Waheed

Alzahrani

Sharif

, et al. Is duplex carotid artery screening prior to CABG justified? Neurosciences (Riyadh) 2019; 24: 122–129.

48.

Naylor

Rantner

Ancetti

, et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. Eur J Vasc Endovasc Surg 2023; 65: 7–111.

49.

Hillis

Smith

Anderson

, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: e123–210.

50.

Qureshi

Alexandrov

Tegeler

, et al. Guidelines for screening of extracranial carotid artery disease: A statement for healthcare professionals from the Multidisciplinary Practice Guidelines Committee of the American Society of Neuroimaging; cosponsored by the Society of Vascular and Interventional Neurology. J Neuroimaging 2007; 17: 19–47.

51.

Augoustides

JG.

Advances in the management of carotid artery disease: Focus on recent evidence and guidelines. J Cardiothorac Vasc Anesth 2012; 26: 166–171.

52.

Venkatachalam

Gray

Mukherjee

Shishehbor

MH.

Contemporary management of concomitant carotid and coronary artery disease. Heart 2011; 97: 175–180.

53.

Narayan

Khan

Das

, et al. Carotid artery screening at the time of coronary artery bypass – Does it influence neurological outcomes? Int J Cardiol 2017; 243: 140–144.

54.

Walicki

Mathiesen

, et al. Strokes after cardiac surgery and relationship to carotid stenosis. Arch Neurol 2009; 66: 1091–1096.

55.

Lawton

Tamis-Holland

Bangalore

, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e18–e114.

56.

Tzoumas

Giannopoulos

Texakalidis

, et al. Synchronous versus staged carotid endarterectomy and coronary artery bypass graft for patients with concomitant severe coronary and carotid artery stenosis: A systematic review and meta-analysis. Ann Vasc Surg 2020; 63: 427–438.e1.

57.

Macellari

Paciaroni

Agnelli

Caso

Perioperative stroke risk in nonvascular surgery. Cerebrovasc Dis 2012; 34: 175–181.

58.

Goldstein

Samsa

Matchar

Oddone

EZ.

Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. Stroke 1998; 29: 750–753.

59.

Naylor

Cuffe

Rothwell

, et al. A systematic review of outcome following synchronous carotid endarterectomy and coronary artery bypass: Influence of surgical and patient variables. Eur J Vasc Endovasc Surg 2003; 26: 230–241.

60.

Biller

Feinberg

Castaldo

, et al. Guidelines for carotid endarterectomy: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1998; 29: 554–562.

61.

SB.

Perioperative stroke: Pathophysiology and management. Korean J Anesthesiol 2018; 71: 3–11.

62.

Meharwal

Mishra

Trehan

Safety and efficacy of one stage off-pump coronary artery operation and carotid endarterectomy. Ann Thorac Surg 2002; 73: 793–797.

63.

Garg

Bansal

Singh

, et al. Combining carotid endarterectomy with off-pump coronary artery bypass graft surgery is safe and effective. Ann Indian Acad Neurol 2015; 18: 419–423.

64.

Ziada

Yadav

Mukherjee

, et al. Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol 2005; 96: 519–523.

65.

Naylor

Mehta

Rothwell

PM.

A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass. Eur J Vasc Endovasc Surg 2009; 37: 379–387.

66.

Zhang

Fan

, et al. A systematic review of early results following synchronous or staged carotid artery stenting and coronary artery bypass grafting. Thorac Cardiovasc Surg 2017; 65: 302–310.

67.

Paraskevas

Nduwayo

Saratzis

Naylor

AR.

Carotid stenting prior to coronary bypass surgery: An updated systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2017; 53: 309–319.

68.

Feldman

Swaminathan

Geleris

, et al. Comparison of trends and in-hospital outcomes of concurrent carotid artery revascularization and coronary artery bypass graft surgery: The United States Experience 2004 to 2012. JACC Cardiovasc Interv 2017; 10: 286–298.

69.

Tomai

Pesarini

Castriota

, et al. Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. JACC Cardiovasc Interv 2011; 4: 560–568.

70.

Zarrintan

Malas

MB.

What is the role of transcarotid artery revascularization?

Adv Surg 2023; 57: 115–140.

71.

Malas

Dakour-Aridi

Wang

, et al. Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg 2019; 69: 92–103.e2.

72.

Vyas

Workneh

Leibowitz

, et al. Evaluating the safety of transcarotid artery revascularization under local anesthesia prior to coronary artery bypass grafting surgery. Ann Vasc Surg 2023; 91: 176–181.

73.

Williams

Olivere

Schroder

, et al. Simultaneous transcarotid artery revascularization with flow reversal and coronary artery bypass grafting: A novel hybrid technique. J Vasc Surg Cases Innov Tech 2019; 5: 572–575.